Search research articles
Contact Us
Filters
Showing results (101-110 of 132) with videos related to
Page
of 14
Sort By:
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 26, 2025
Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l'étude CAN-BIND-1
Chloé Stengel, Benjamin Schwartzmann, Raaj Chatterjee, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 15, 2022
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study
Prabhjot Dhami, Lena C Quilty, Benjamin Schwartzmann, et al.
Journal of Affective Disorders
|
June 12, 2024
Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report
Abraham Nunes, Barbara Pavlova, Jasmyn E A Cunningham, et al.
Translational Psychiatry
|
October 11, 2024
Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume
Raegan Mazurka, Kate L Harkness, Stefanie Hassel, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)
Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
Translational Psychiatry
|
September 11, 2021
Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
Antoine Yrondi, Laura M Fiori, Nikita Nogovitsyn, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 24, 2025
Standardized EEG for multi-site biomarker-informed trials: Implementation in the Canadian Biomarker Integration Network in Depression
Benjamin Schwartzmann, Prabhjot Dhami, Raaj Chatterjee, et al.
Journal of Affective Disorders
|
November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study
Anusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Translational Psychiatry
|
September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry
|
May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 132) with videos related to
Sort By:
Page
of 14
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
December 26, 2025
Modulation of Brain Temporal Complexity During Treatment for Depression: A CAN-BIND-1 Study Report: Modulation de la complexité temporelle du cerveau pendant le traitement de la dépression: rapport de l'étude CAN-BIND-1
Chloé Stengel, Benjamin Schwartzmann, Raaj Chatterjee, et al.
Biological Psychiatry. Cognitive Neuroscience and Neuroimaging
|
January 15, 2022
Response Inhibition and Predicting Response to Pharmacological and Cognitive Behavioral Therapy Treatments for Major Depressive Disorder: A Canadian Biomarker Integration Network for Depression Study
Prabhjot Dhami, Lena C Quilty, Benjamin Schwartzmann, et al.
Journal of Affective Disorders
|
June 12, 2024
Depression-Anxiety Coupling Strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report
Abraham Nunes, Barbara Pavlova, Jasmyn E A Cunningham, et al.
Translational Psychiatry
|
October 11, 2024
Endocannabinoid concentrations in major depression: effects of childhood maltreatment and relation to hippocampal volume
Raegan Mazurka, Kate L Harkness, Stefanie Hassel, et al.
Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
|
April 30, 2025
Predicting Relapse of Depressive Episodes During Maintenance Treatment: The Canadian Biomarker Integration Network in Depression (CAN-BIND) Wellness Monitoring in Major Depressive Disorder Study: Prédire la rechute d'épisodes dépressifs pendant le traitement d'entretien : Une étude de suivi du bien-être dans les troubles dépressifs majeurs du Réseau canadien d'intégration des biomarqueurs pour la dépression (CAN-BIND)
Raymond W Lam, Katerina Rnic, John-Jose Nunez, et al.
Translational Psychiatry
|
September 11, 2021
Association between the expression of lncRNA BASP-AS1 and volume of right hippocampal tail moderated by episode duration in major depressive disorder: a CAN-BIND 1 report
Antoine Yrondi, Laura M Fiori, Nikita Nogovitsyn, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
|
July 24, 2025
Standardized EEG for multi-site biomarker-informed trials: Implementation in the Canadian Biomarker Integration Network in Depression
Benjamin Schwartzmann, Prabhjot Dhami, Raaj Chatterjee, et al.
Journal of Affective Disorders
|
November 24, 2017
The comparative effectiveness of electroencephalographic indices in predicting response to escitalopram therapy in depression: A pilot study
Anusha Baskaran, Faranak Farzan, Roumen Milev, et al.
Translational Psychiatry
|
September 6, 2022
Effects of CYP2C19 and CYP2D6 gene variants on escitalopram and aripiprazole treatment outcome and serum levels: results from the CAN-BIND 1 study
Farhana Islam, Victoria S Marshe, Leen Magarbeh, et al.
The Journal of Clinical Psychiatry
|
May 16, 2019
Predicting Worsening Suicidal Ideation With Clinical Features and Peripheral Expression of Messenger RNA and MicroRNA During Antidepressant Treatment
Raoul Belzeaux, Laura M Fiori, Juan Pablo Lopez, et al.
Page
of 14